Notizie su Haisco Pharmaceutical Group

002653 · SZSE · CNY

62,18 ¥+0,40%+0,25 ¥

Chiusura · 30 settembre 2026

Ultime notizie

Titoli nella lingua originale della fonte.

Lilly’s latest China drug deal; Immunovant’s setback in lupus (si apre in una nuova scheda)
24 set 2026
AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group (si apre in una nuova scheda)
GlobeNewswire · 8 set 2026
Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners (si apre in una nuova scheda)
PR Newswire · 25 ago 2026
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why (si apre in una nuova scheda)
Zacks · 19 ago 2026
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights (si apre in una nuova scheda)
4 ago 2026
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data (si apre in una nuova scheda)
TMX Newsfile · 14 lug 2026
Haisco and Nuvectis sign licensing deal for two drugs (si apre in una nuova scheda)
Hospital Management · 24 giu 2026
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications (si apre in una nuova scheda)
23 giu 2026
Nuvectis Expands Pipeline with Haisco Licensing Agreement for Two Clinical-Stage Drug Candidates (NVCT) (si apre in una nuova scheda)
InvestorsHub · 22 giu 2026
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds (si apre in una nuova scheda)
GlobeNewswire · 22 giu 2026
Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets (si apre in una nuova scheda)
Simply Wall St. · 7 giu 2026
Eli Lilly Broadens Beyond Obesity Drugs With Vaccine And Genetic Bets (si apre in una nuova scheda)
Simply Wall St. · 6 giu 2026
Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations (si apre in una nuova scheda)
3 giu 2026
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas (si apre in una nuova scheda)
PR Newswire · 1 giu 2026
AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development (si apre in una nuova scheda)
Insider Monkey · 22 apr 2026
Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion (si apre in una nuova scheda)
12 gen 2026